Safety and efficacy of high-current tTIS targeting left sgACC for major depressive disorder: A randomized, double-blind, sham-controlled trial. (linkinghub.elsevier.com)

Authors: Wang M … Zhang X Journal: Cell Reports Medicine Published: 2026-10-15 DOI: https://doi.org/10.1016/j.xcrm.2026.103112